Literature DB >> 31933785

A case report on epithelioid inflammatory myofibroblastic sarcoma in the abdominal cavity.

Shijie Zhang1, Zhiguang Wang2.   

Abstract

Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare entity and a novel variant of the inflammatory myofibroblastic tumor (IMT). We report the occurrence and specific characteristics of EMIS in an adult woman. Eleven months after the operation, the patient had a recurrence and multiple metastases in the abdominal cavity. Since the tumor was spreading all over the abdominal cavity and ALK staining of the tumor was positive, crizotinib was suggested as adjuvant therapy. But she failed to respond to the crizotinib treatment and died of organ failure three months later. IJCEP
Copyright © 2019.

Entities:  

Keywords:  ALK; Epithelioid inflammatory myofibroblastic sarcoma; crizotinib

Year:  2019        PMID: 31933785

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  2 in total

Review 1.  Inflammatory Myofibroblastic Tumour: State of the Art.

Authors:  Louis Gros; Angelo Paolo Dei Tos; Robin L Jones; Antonia Digklia
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

2.  Epithelioid inflammatory myofibroblastic sarcoma: the youngest case reported.

Authors:  Sajida Batool; Arvind Ahuja; Devender Singh Chauhan; Minakshi Bhardwaj; Atul Kumar Meena
Journal:  Autops Case Rep       Date:  2021-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.